---
kind: "section"
citation: "21 C.F.R. § 106.1"
title: "21"
number: "106.1"
heading: "Status and applicability of the regulations in part 106."
url: "https://uscodex.org/cfr/21/106.1"
---

# §106.1. Status and applicability of the regulations in part 106.

- (a) The criteria set forth in subparts [B](/cfr/21/subpartB.md), [C](/cfr/21/subpartC.md), and D of this part prescribe the steps that manufacturers shall take under section [412(b)(2)](/cfr/21/412.md?p=b-2) and [(b)(3)](/cfr/21/412.md?p=b-3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. [350a(b)(2)](/usc/21/350a.md?p=b-2) and [(b)(3)](/usc/21/350a.md?p=b-3)) in processing infant formula. If the processing of the formula does not comply with any regulation in subparts [B](/cfr/21/subpartB.md), [C](/cfr/21/subpartC.md), or D of this part, the formula will be deemed to be adulterated under [section 412(a)(3)](/cfr/21/412.md?p=a-3) of the Federal Food, Drug, and Cosmetic Act.
- (b) The criteria set forth in [subpart E](/cfr/21/subpartE.md) of this part prescribe the requirements for quality factors that infant formula shall meet under [section 412(b)(1)](/cfr/21/412.md?p=b-1) of the Federal Food, Drug, and Cosmetic Act. If the formula fails to comply with any regulation in [subpart E](/cfr/21/subpartE.md) of this part, it will be deemed to be adulterated under [section 412(a)(2)](/cfr/21/412.md?p=a-2) of the Federal Food, Drug, and Cosmetic Act.
- (c) The criteria set forth in [subpart F](/cfr/21/subpartF.md) of this part prescribe records requirements for quality factors under [section 412(b)(1)](/cfr/21/412.md?p=b-1) of the Federal Food, Drug, and Cosmetic Act and for good manufacturing practices and quality control procedures, including distribution and audit records, under [section 412(b)(2)](/cfr/21/412.md?p=b-2). If an infant formula manufacturer fails to comply with the quality factor record requirements in [subpart F](/cfr/21/subpartF.md) of this part with respect to an infant formula, the formula will be deemed to be adulterated under [section 412(a)(2)](/cfr/21/412.md?p=a-2) of the Federal Food, Drug, and Cosmetic Act. If an infant formula manufacturer fails to comply with the good manufacturing practices or quality control procedures record requirements in [subpart F](/cfr/21/subpartF.md) of this part with respect to an infant formula, the infant formula will be deemed to be adulterated under [section 412(a)(3)](/cfr/21/412.md?p=a-3) of the Federal Food, Drug, and Cosmetic Act. The criteria set forth in [subpart F](/cfr/21/subpartF.md) of this part also implement record retention requirements under [section 412(b)(4)](/cfr/21/412.md?p=b-4) of the Federal Food, Drug, and Cosmetic Act. Failure to comply with any regulation in [subpart F](/cfr/21/subpartF.md) of this part is a violation of [section 301(e)](/cfr/21/301.md?p=e) of the Federal Food, Drug, and Cosmetic Act ([21 U.S.C. 331(e)](/usc/21/331.md?p=e)).
- (d) The criteria set forth in [subpart G](/cfr/21/subpartG.md) of this part describe, in part, certain good manufacturing practices, quality control procedures, and quality factor records requirements under section [412(b)(1)](/cfr/21/412.md?p=b-1) and [(b)(2)](/cfr/21/412.md?p=b-2) of the Federal Food, Drug and Cosmetic Act. If an infant formula manufacturer fails to comply with such records requirements with respect to an infant formula, the infant formula will be deemed to be adulterated under section [412(a)(2)](/cfr/21/412.md?p=a-2) or [(a)(3)](/cfr/21/412.md?p=a-3) of the Federal Food, Drug, and Cosmetic Act, as applicable. The criteria set forth in [subpart G](/cfr/21/subpartG.md) of this part also describe the circumstances in which an infant formula manufacturer is required to register with, submit to, or notify the Food and Drug Administration, and the content of a registration, submission, or notification, under section [412(c)](/cfr/21/412.md?p=c), [(d)](/cfr/21/412.md?p=d), and [(e)](/cfr/21/412.md?p=e) of the Federal Food, Drug, and Cosmetic Act. Failure to comply with any regulation in [subpart G](/cfr/21/subpartG.md) of this part is a violation of [section 301(s)](/cfr/21/301.md?p=s) of the Federal Food, Drug, and Cosmetic Act.

## Notes

### Authority

Authority: 21 U.S.C. 321, 342, 350a, 371.

### Source

Source: 79 FR 8059, Feb. 10, 2014, unless otherwise noted.